IPP Bureau
Indian pharma growth likely to moderate in FY23: ICRA
By IPP Bureau - April 07, 2022
Headwinds related to pricing pressures and rising raw material costs will result in some contraction in margins in Q4 FY22 and FY23
All India Institute of Ayurveda signs MoU with Safdarjung hospital
By IPP Bureau - April 07, 2022
The MoU sets down the guidelines for the establishment of an integrative medicine unit, joint research and academic activities in various fields of interest in Ayurveda and modern medicine
Alembic gets USFDA tentative approval for dabigatran etexilate capsules
By IPP Bureau - April 07, 2022
The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Pradaxa Capsules of Boehringer lngelheim
Lupin launches Merzee capsules in the United States
By IPP Bureau - April 07, 2022
Merzee is a generic equivalent of Taytulla of Allergan Pharmaceuticals International
CDMOs shifting focus to meet future demand
By IPP Bureau - April 07, 2022
An integrated and agile approach enables the pharmaceutical CDMO industry to simplify manufacturing as it moves from primary care medicines to specialty medicines
New ultra-sensitive lyo-ready PCR reagents unlock lower detection limits in lyophilised multiplex diagnostic assays
By IPP Bureau - April 07, 2022
The new reagents will bring the exceptional sensitivity of the company’s liquid format 1-step RT-qPCR reagents to a freeze-dryable format
Gufic Biosciences receives DCGI approval for Thymosin Alpha-1 to treat Covid-19
By IPP Bureau - April 06, 2022
Immunocin, an Immuno-modulator drug, significantly reduced the risk of death in the Phase 3 clinical trial in adult patients with moderate-to-severe Covid-19
Pristyn Care’s new app enables location-based discovery of doctors
By IPP Bureau - April 06, 2022
An upgraded, state-of-the-art integrated app, helps easy discovery of expert surgeons for convenient in-clinic or online consultation
Hataali wins US patent for the use of blockchain in advanced medicinal therapy
By IPP Bureau - April 06, 2022
The Blockchain-based solution was awarded the 2021 Bionow Technical Service Award
MilliporeSigma acquires MAST platform from Lonza
By IPP Bureau - April 06, 2022
MilliporeSigma to become the first company to offer a fully integrated ecosystem for advanced process technologies
BioFluidica to introduce next-generation biomarker isolation platform
By IPP Bureau - April 06, 2022
BioFluidica LiquidScan harnesses the power of microfluidics
Singlera Genomics announces research collaboration with Astellas Pharma
By IPP Bureau - April 06, 2022
The aim is to pursue methylation-based tools to better understand biological reactions to pharmaceuticals
GE Healthcare and Elekta sign global collaboration agreement
By IPP Bureau - April 06, 2022
GE Healthcare and Elekta aim to meet the major need for radiotherapy solutions across both developed and developing markets
Iktos and Teijin Pharma to co-develop technology for small molecule drug discovery
By IPP Bureau - April 06, 2022
Iktos and Teijin Pharma will collaborate in developing new AI technology aiming to bring further improvement and speed to the drug design process
ENTOD Pharma bullish on Macushield sales
By IPP Bureau - April 06, 2022
Macushield tablets assist with age-related macular degeneration, diabetic retinopathy and improves overall vision
